It has been discovered that overexpression of DNA-PK in tumor tissues after radiation therapy and DNA-PK inhibition decreases DNA repair, indicating that DNA-PK plays a role in overcoming the drug resistance of tumor cells and that DNA-PK inhibition has a superior therapeutic impact. This evidence concerns the gene PRKDC and neoplasm.